GlassScriptPhysician profile
Tani Schare
NPI 1831579531
$3,419.60
in general payments reported to CMS, 2019-2025
19 companies · $1,164 in 2025
The $1,164 reported for 2025 was more than what 87% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $123 · 2022: $328 · 2023: $481 · 2024: $1,323 · 2025: $1,164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,968.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,968.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,807.04 | 2022-2025 | |
| Novo Nordisk INC | $357.12 | 2022-2025 | Wegovy, Ozempic |
| Phathom Pharmaceuticals, INC. | $220.41 | 2024 | Voquezna |
| Lilly USA, LLC | $183.13 | 2022-2025 | Zepbound, Jardiance, Mounjaro |
| Biogen, INC. | $117.65 | 2024 | Zurzuvae |
| Abiomed | $113.79 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $95.52 | 2025 | Wainua |
| Acadia Pharmaceuticals INC | $93.29 | 2024 | Nuplazid |
| Sanofi Pasteur INC. | $89.68 | 2021 | |
| Inspire Medical Systems, INC. | $87.81 | 2023 | Inspire |
| Astellas Pharma US INC | $48.43 | 2024-2025 | Veozah |
| Corcept Therapeutics | $44.01 | 2024 | Korlym |
| Merck Sharp & Dohme LLC | $39.09 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $33.48 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $23.37 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.45 | 2025 | Xifaxan |
| Abbott Laboratories | $16.90 | 2023 | Freestyle Libre |
| Baxter Healthcare | $15.32 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Avion Pharmaceuticals | $15.11 | 2023 | NP Thyroid 60 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tani Schare listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.